Staff from The Tanzania Medicines and Medical Devices Authority (TMDA) attended the third (3rd) PAVIA training which was conducted from 14-18 June, 2021. The training was facilitated by the Lareb, the European Medicine Agency (EMA) and FDA Ghana. The training aimed at building capacity to the NMRAs staff on Risk evaluation and communication and also assessment of Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs) received from manufacturers and Marketing Authorization Holders (MAHs). A total of twelve participants who participates in clinical trials evaluation attended the training.
Staff from the National PV team
TMDA organized a task force meeting between National PV Centre team with staff from University of Dodoma (UDOM) conducted at Morogoro, Tanzania to finalize the establishment of the electronic reporting tool for reporting of ADRs associated with the use of TB medicines (aDSM). The meeting was conducted July 2021. The tool may be found on TMDA website and an android application from play store.
One hundred and forty (140) health care workers (HCW) from 28 facilities in eleven (11) regions were sensitized on Pharmacovigilance. The objectives were to equip the HCWs with knowledge and discuss the issue of under reporting of adverse events especially ones associated with the use of anti TB medicines. Another objective was to orient the HCWs with the use of various reporting tools that includes the use of electronic reporting tools for reporting of ADRs.